Javascript must be enabled to continue!
Vitamin D and Vitamin D Receptor in Scleroderma Subtypes
View through CrossRef
Vitamin D Receptor (VDR) is a member of the nuclear hormone receptor family. 1,25(OH)2D, a form of metabolically active vitamin D3 form, is the ligand of VDR. When VDR and 1,25(OH)2D are connected, many genes start to molecular interaction reactions that will modulate the transcription. VDR has been shown to be a negative regulator of the transforming growth factor beta-1 / Smad (TGF-β1 / Smad) signalling pathway. TGF-β1 / Smad signalling is important in the pathogenesis of scleroderma (SSc). Vitamin D has pleiotropic effects including immunomodulatory and antifibrotic properties in scleroderma pathogenesis. The aim of this study was to investigate the expression of VDR and the levels of vitamin D in scleroderma subtypes and study the possible correlation between the two parameters. 28 SSc patients and 30 healthy controls were included in the study and they were classified according to the 2013 ACR / EULAR criteria and Rodnan Scores were calculated. 14 were of the limited type and 14 were of the diffuse type of scleroderma. Vitamin D levels were determined in serum. Vitamin D level was measured by chemiluminescence immunometric assay. VDR gene expression was determined by quantitative PCR in isolated RNAs from the blood. Changes in mRNA levels were analysed and beta-actin was used as the housekeeping gene. Also, TGF-β1 gene expressions were determined. VDR gene expressions in diffuse type scleroderma patients were significantly decreased compared to the control. TGF-β1 gene expressions were increased in diffuse type scleroderma. It was found that VDR gene expression in limited type scleroderma patients did not show any significant difference when compared to control. Vitamin D levels and VDR gene expressions showed no correlation in scleroderma subtypes. VDR gene expression decreased in patients with diffuse type scleroderma and showed negative correlation with the Rodnan score and TGF-β1 gene expressions. There was no significant difference between vitamin D and VDR levels.
Title: Vitamin D and Vitamin D Receptor in Scleroderma Subtypes
Description:
Vitamin D Receptor (VDR) is a member of the nuclear hormone receptor family.
1,25(OH)2D, a form of metabolically active vitamin D3 form, is the ligand of VDR.
When VDR and 1,25(OH)2D are connected, many genes start to molecular interaction reactions that will modulate the transcription.
VDR has been shown to be a negative regulator of the transforming growth factor beta-1 / Smad (TGF-β1 / Smad) signalling pathway.
TGF-β1 / Smad signalling is important in the pathogenesis of scleroderma (SSc).
Vitamin D has pleiotropic effects including immunomodulatory and antifibrotic properties in scleroderma pathogenesis.
The aim of this study was to investigate the expression of VDR and the levels of vitamin D in scleroderma subtypes and study the possible correlation between the two parameters.
28 SSc patients and 30 healthy controls were included in the study and they were classified according to the 2013 ACR / EULAR criteria and Rodnan Scores were calculated.
14 were of the limited type and 14 were of the diffuse type of scleroderma.
Vitamin D levels were determined in serum.
Vitamin D level was measured by chemiluminescence immunometric assay.
VDR gene expression was determined by quantitative PCR in isolated RNAs from the blood.
Changes in mRNA levels were analysed and beta-actin was used as the housekeeping gene.
Also, TGF-β1 gene expressions were determined.
VDR gene expressions in diffuse type scleroderma patients were significantly decreased compared to the control.
TGF-β1 gene expressions were increased in diffuse type scleroderma.
It was found that VDR gene expression in limited type scleroderma patients did not show any significant difference when compared to control.
Vitamin D levels and VDR gene expressions showed no correlation in scleroderma subtypes.
VDR gene expression decreased in patients with diffuse type scleroderma and showed negative correlation with the Rodnan score and TGF-β1 gene expressions.
There was no significant difference between vitamin D and VDR levels.
Related Results
Abstract IA22: Autoimmune rheumatic diseases and cancer
Abstract IA22: Autoimmune rheumatic diseases and cancer
Abstract
Some rheumatic disease autoantibodies are powerful markers of subgroups of patients who have distinct disease phenotypes and trajectories. Of particular int...
Scleroderma spp. in Indonesia : Poisoning Case and Potential Utilization
Scleroderma spp. in Indonesia : Poisoning Case and Potential Utilization
Abstract : Mushroom are functional food which has been consumed for long time due to the various benefits and are rich in nutrients for health. Even though it is not the main food ...
Analysis of the current vitamin A terminology and dietary regulations from vitamin A1 to vitamin A5
Analysis of the current vitamin A terminology and dietary regulations from vitamin A1 to vitamin A5
Abstract: Dietary recommendations on vitamin intake for human food fortification concerning vitamin A in various countries, larger economic zones and international organizations ar...
Vitamin D Deficiency and Supplementation in Irritable Bowel Syndrome: Retrospective Evaluation of Subtype and Sex-Based Differences
Vitamin D Deficiency and Supplementation in Irritable Bowel Syndrome: Retrospective Evaluation of Subtype and Sex-Based Differences
Background and Objectives: Irritable bowel syndrome (IBS) is a prevalent functional gastrointestinal disorder with diverse subtypes. Recent evidence has suggested a link between vi...
Vitamin D and the Immune System. When? Why? How?
Vitamin D and the Immune System. When? Why? How?
Vitamin D, called “the sunshine vitamin” is essential for the good functioning of the human body. Vitamin D generates its principal effects via the vitamin D receptor (VDR), a spec...
Use of Extracorporeal Photopheresis in Scleroderma: A Review
Use of Extracorporeal Photopheresis in Scleroderma: A Review
<b><i>Background:</i></b> Scleroderma is a heterogeneous group of diseases that can be localized or systemic. Localized scleroderma is a fibrosis of the ski...
A case of Hypothyroidism with associated Scleroderma and Eczema
A case of Hypothyroidism with associated Scleroderma and Eczema
Background: This case report describes an unusual case of hypothyroidism as the symptoms especially fatigue, body aches and pain in hands of our patient didn’t improve despite adeq...
A Challenging Case of Scleroderma: Diagnosis, Treatment, and Management
A Challenging Case of Scleroderma: Diagnosis, Treatment, and Management
Scleroderma is a relatively rare autoimmune disorder that causes progressive hardening,
tightening, and scarring of the skin, as well as internal organ involvement. This case study...

